The Spring 2012 season of CACAO has started!
HUMAN:APOA1
Contents |
| Species (Taxon ID) | Homo sapiens (Human). (taxon:9606) | |
| Gene Name(s) | APOA1 | |
| Protein Name(s) |
| |
| External Links | ||
| UniProt Identifier | APOA1_HUMAN | |
| UniProt Accessions | P02647, A8K866, Q6LDN9, Q6Q785, Q9UCS8, Q9UCT8, | |
| EMBL | J00098, X01038, X02162, X00566, M11791, X07496, M27875, M29068, AY422952, AY555191, A14829, AK292231, EF444948, EF444948, EF444948, EF444948, EF444948, CH471065, BC005380, BC110286, | |
| PIR | A90947, | |
| RefSeq | NP_000030.1, | |
| PDB | 1AV1, 1GW3, 1GW4, 1ODP, 1ODQ, 1ODR, 2A01, 3J00, 3K2S, | |
| IntAct | P02647, | |
| Ensembl | ENST00000236850, ENST00000359492, ENST00000375320, ENST00000375323, | |
| Pfam | PF01442, | |
Annotations
| Qualifier | GO ID | GO term name | Reference | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| GO:0030139 |
endocytic vesicle |
IDA: Inferred from Direct Assay |
C |
Source: UniProtKB |
||||
| GO:0005788 |
endoplasmic reticulum lumen |
EXP: Inferred from Experiment |
C |
Source: Reactome |
||||
| GO:0034364 |
high-density lipoprotein particle |
IEA |
C |
Source: UniProtKB-KW |
||||
| GO:0034191 |
apolipoprotein A-I receptor binding |
IPI: Inferred from Physical Interaction |
F |
Source: UniProtKB |
||||
| GO:0001540 |
beta-amyloid binding |
IDA: Inferred from Direct Assay |
F |
Source: UniProtKB |
||||
| GO:0015485 |
cholesterol binding |
IDA: Inferred from Direct Assay |
F |
Source: UniProtKB |
||||
| GO:0017127 |
cholesterol transporter activity |
IMP: Inferred from Mutant Phenotype |
F |
Source: UniProtKB |
||||
| GO:0019899 |
enzyme binding |
IPI: Inferred from Physical Interaction |
F |
Source: UniProtKB |
||||
| GO:0042802 |
identical protein binding |
IPI: Inferred from Physical Interaction |
F |
Source: UniProtKB |
||||
| GO:0070325 |
lipoprotein receptor binding |
IPI: Inferred from Physical Interaction |
F |
Source: UniProtKB |
||||
| GO:0060228 |
phosphatidylcholine-sterol O-acyltransferas... |
IDA: Inferred from Direct Assay |
F |
Source: UniProtKB |
||||
| GO:0005543 |
phospholipid binding |
IDA: Inferred from Direct Assay |
F |
Source: UniProtKB |
||||
| GO:0033344 |
cholesterol efflux |
IDA: Inferred from Direct Assay |
P |
Source: UniProtKB |
||||
| GO:0042632 |
cholesterol homeostasis |
IMP: Inferred from Mutant Phenotype |
P |
Source: UniProtKB |
||||
| GO:0008203 |
cholesterol metabolic process |
IDA: Inferred from Direct Assay |
P |
Source: UniProtKB-KW |
required field missing | |||
| GO:0034380 |
high-density lipoprotein particle assembly |
IDA: Inferred from Direct Assay |
P |
Source: UniProtKB |
||||
| GO:0042157 |
lipoprotein metabolic process |
IEA |
P |
Source: InterPro |
||||
| GO:0006656 |
phosphatidylcholine biosynthetic process |
IDA: Inferred from Direct Assay |
P |
Source: UniProtKB |
||||
| GO:0033700 |
phospholipid efflux |
IDA: Inferred from Direct Assay |
P |
Source: UniProtKB |
||||
| GO:0010873 |
positive regulation of cholesterol esterifi... |
IDA: Inferred from Direct Assay |
P |
Source: UniProtKB |
||||
| GO:0034384 |
high-density lipoprotein particle clearance |
IDA: Inferred from Direct Assay |
P |
required field missing | ||||
| GO:0051345 |
positive regulation of hydrolase activity |
IDA: Inferred from Direct Assay |
P |
Source: UniProtKB |
||||
| GO:0050821 |
protein stabilization |
IDA: Inferred from Direct Assay |
P |
Source: UniProtKB |
||||
| GO:0010903 |
negative regulation of very-low-density lipoprotein particle remodeling |
IDA: Inferred from Direct Assay |
P |
required field missing | ||||
| GO:0043691 |
reverse cholesterol transport |
IMP: Inferred from Mutant Phenotype |
P |
Source: UniProtKB |
||||
| GO:0070508 |
cholesterol import |
IMP: Inferred from Mutant Phenotype |
P |
required field missing | ||||
| GO:0001540 |
beta-amyloid binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0002576 |
platelet degranulation |
Reactome:REACT_318 |
TAS: Traceable Author Statement |
P |
||||
| GO:0002740 |
negative regulation of cytokine secretion involved in immune response |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005543 |
phospholipid binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0005576 |
extracellular region |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005576 |
extracellular region |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005576 |
extracellular region |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0243 |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13407 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13408 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13459 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13548 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13575 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13604 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13610 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13674 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13678 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13688 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13706 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13717 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13735 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13762 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13783 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_13803 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_21324 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_22360 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_6727 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_6734 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_6813 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_6852 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_75876 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005576 |
extracellular region |
Reactome:REACT_75905 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005615 |
extracellular space |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0005788 |
endoplasmic reticulum lumen |
Reactome:REACT_6813 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005788 |
endoplasmic reticulum lumen |
Reactome:REACT_6915 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005886 |
plasma membrane |
Reactome:REACT_13459 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005886 |
plasma membrane |
Reactome:REACT_13575 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005886 |
plasma membrane |
Reactome:REACT_13602 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005886 |
plasma membrane |
Reactome:REACT_13622 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005886 |
plasma membrane |
Reactome:REACT_13627 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005886 |
plasma membrane |
Reactome:REACT_13688 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005886 |
plasma membrane |
Reactome:REACT_13762 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005886 |
plasma membrane |
Reactome:REACT_15367 |
TAS: Traceable Author Statement |
C |
||||
| GO:0006629 |
lipid metabolic process |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006629 |
lipid metabolic process |
Reactome:REACT_602 |
TAS: Traceable Author Statement |
P |
||||
| GO:0006656 |
phosphatidylcholine biosynthetic process |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0006810 |
transport |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006869 |
lipid transport |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006869 |
lipid transport |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0007186 |
G-protein coupled receptor protein signaling pathway |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0007596 |
blood coagulation |
Reactome:REACT_604 |
TAS: Traceable Author Statement |
P |
||||
| GO:0008202 |
steroid metabolic process |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0008203 |
cholesterol metabolic process |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0008203 |
cholesterol metabolic process |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0008289 |
lipid binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0010873 |
positive regulation of cholesterol esterification |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0010903 |
negative regulation of very-low-density lipoprotein particle remodeling |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0015485 |
cholesterol binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0017127 |
cholesterol transporter activity |
IMP: Inferred from Mutant Phenotype |
F |
|||||
| GO:0019899 |
enzyme binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0030139 |
endocytic vesicle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0030141 |
stored secretory granule |
Reactome:REACT_21324 |
TAS: Traceable Author Statement |
C |
||||
| GO:0030168 |
platelet activation |
Reactome:REACT_798 |
TAS: Traceable Author Statement |
P |
||||
| GO:0030301 |
cholesterol transport |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0031410 |
cytoplasmic vesicle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0032488 |
Cdc42 protein signal transduction |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0033344 |
cholesterol efflux |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0033344 |
cholesterol efflux |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0033344 |
cholesterol efflux |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0033700 |
phospholipid efflux |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0033700 |
phospholipid efflux |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0034190 |
apolipoprotein receptor binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0034191 |
apolipoprotein A-I receptor binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0034361 |
very-low-density lipoprotein particle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0034364 |
high-density lipoprotein particle |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0034364 |
high-density lipoprotein particle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0034364 |
high-density lipoprotein particle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0034364 |
high-density lipoprotein particle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0034366 |
spherical high-density lipoprotein particle |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0034375 |
high-density lipoprotein particle remodeling |
IC: Inferred by Curator |
GO:0060228 |
P |
||||
| GO:0034380 |
high-density lipoprotein particle assembly |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0034384 |
high-density lipoprotein particle clearance |
IC: Inferred by Curator |
GO:0070325 |
P |
||||
| GO:0042157 |
lipoprotein metabolic process |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0042157 |
lipoprotein metabolic process |
Reactome:REACT_13621 |
TAS: Traceable Author Statement |
P |
||||
| GO:0042157 |
lipoprotein metabolic process |
Reactome:REACT_6823 |
TAS: Traceable Author Statement |
P |
||||
| GO:0042157 |
lipoprotein metabolic process |
Reactome:REACT_6841 |
TAS: Traceable Author Statement |
P |
||||
| GO:0042632 |
cholesterol homeostasis |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0042802 |
identical protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0043691 |
reverse cholesterol transport |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0044255 |
cellular lipid metabolic process |
Reactome:REACT_22279 |
TAS: Traceable Author Statement |
P |
||||
| GO:0050713 |
negative regulation of interleukin-1 beta secretion |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0050821 |
protein stabilization |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0051345 |
positive regulation of hydrolase activity |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0055085 |
transmembrane transport |
Reactome:REACT_15480 |
TAS: Traceable Author Statement |
P |
||||
| GO:0055085 |
transmembrane transport |
Reactome:REACT_15518 |
TAS: Traceable Author Statement |
P |
||||
| GO:0060228 |
phosphatidylcholine-sterol O-acyltransferase activator activity |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0070508 |
cholesterol import |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0070653 |
high-density lipoprotein particle receptor binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0070653 |
high-density lipoprotein particle receptor binding |
IPI: Inferred from Physical Interaction |
F |
|||||
|
contributes_to |
GO:0017127 |
cholesterol transporter activity |
IDA: Inferred from Direct Assay |
F |
| |||
| edit table |
Notes
References
See Help:References for how to manage references in GONUTS.
- ↑ 1.0 1.1 Koldamova RP et al. (2001) Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity. Biochemistry 40: 3553-60 PubMed GONUTS page
- ↑ 2.0 2.1 Furlaneto CJ et al. (2002) Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids 37: 925-8 PubMed GONUTS page
- ↑ Ritter M et al. (2002) Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I. Genomics 79: 693-702 PubMed GONUTS page
- ↑ Fitzgerald ML et al. (2002) Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem 277: 33178-87 PubMed GONUTS page
- ↑ Weinberg RB et al. (2003) Structure and interfacial properties of human apolipoprotein A-V. J Biol Chem 278: 34438-44 PubMed GONUTS page
- ↑ Didangelos A et al. (2010) Proteomics characterization of extracellular space components in the human aorta. Mol Cell Proteomics 9: 2048-62 PubMed GONUTS page
- ↑ 7.0 7.1 7.2 7.3 Fielding CJ et al. (1972) A protein cofactor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun 46: 1493-8 PubMed GONUTS page
- ↑ 8.0 8.1 8.2 8.3 Nofer JR et al. (2006) Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J Lipid Res 47: 794-803 PubMed GONUTS page
- ↑ 9.0 9.1 9.2 9.3 9.4 9.5 Hovingh GK et al. (2004) A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J Am Coll Cardiol 44: 1429-35 PubMed GONUTS page
- ↑ Boucher J et al. (2004) Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity. J Lipid Res 45: 849-58 PubMed GONUTS page
- ↑ Furukawa Y et al. (1992) Interaction of rat lecithin-cholesterol acyltransferase with rat apolipoprotein A-I and with lecithin-cholesterol vesicles. J Biochem 111: 413-8 PubMed GONUTS page
- ↑ Neufeld EB et al. (2004) The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J Biol Chem 279: 15571-8 PubMed GONUTS page
- ↑ Fournier N et al. (1999) Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes. Atherosclerosis 147: 227-35 PubMed GONUTS page
- ↑ 14.0 14.1 14.2 Smith JD et al. (2004) ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I. J Lipid Res 45: 635-44 PubMed GONUTS page
- ↑ 15.0 15.1 15.2 Remaley AT et al. (2001) Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun 280: 818-23 PubMed GONUTS page
- ↑ Mancone C et al. (2007) Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF. Proteomics 7: 143-54 PubMed GONUTS page
- ↑ Weisgraber KH & Mahley RW (1978) Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem 253: 6281-8 PubMed GONUTS page
- ↑ Cheung MC et al. (1986) Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. J Lipid Res 27: 1135-44 PubMed GONUTS page
- ↑ Christoffersen C et al. (2006) Isolation and characterization of human apolipoprotein M-containing lipoproteins. J Lipid Res 47: 1833-43 PubMed GONUTS page
- ↑ Ritter MC & Scanus AM (1977) Role of apolipoprotein A-I in the structure of human serum high density lipoproteins. Reconstitution studies. J Biol Chem 252: 1208-16 PubMed GONUTS page
- ↑ 21.0 21.1 Vishnyakova TG et al. (2003) Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J Biol Chem 278: 22771-80 PubMed GONUTS page
- ↑ Gong EL et al. (1994) Structural and functional properties of human and mouse apolipoprotein A-I. Biochim Biophys Acta 1213: 335-42 PubMed GONUTS page
- ↑ Mukhamedova N et al. (2007) The role of different regions of ATP-binding cassette transporter A1 in cholesterol efflux. Biochemistry 46: 9388-98 PubMed GONUTS page
- ↑ Sorenson RC et al. (1995) Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc Natl Acad Sci U S A 92: 7187-91 PubMed GONUTS page
- ↑ Thuahnai ST et al. (2004) Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure. J Biol Chem 279: 12448-55 PubMed GONUTS page
- ↑ Pilon A et al. (2000) Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake. Arterioscler Thromb Vasc Biol 20: 1074-81 PubMed GONUTS page
- ↑ Wang WQ et al. (1998) Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J Biol Chem 273: 17391-8 PubMed GONUTS page